Avalo Therapeutics (AVTX) News Today → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free AVTX Stock Alerts $9.59 -0.05 (-0.52%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13, 2024 | investorplace.comAVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q1 2024May 13, 2024 | finanznachrichten.deAvalo Therapeutics: Avalo Reports First Quarter 2024 Financial Results and Provides Business UpdatesMay 13, 2024 | globenewswire.comAvalo Reports First Quarter 2024 Financial Results and Provides Business UpdatesApril 17, 2024 | msn.comOppenheimer Upgrades Avalo Therapeutics (AVTX)April 17, 2024 | msn.comAvalo Therapeutics (AVTX) Price Target Increased by 4566.67% to 35.70April 2, 2024 | benzinga.comWhy VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving PremarketApril 2, 2024 | globenewswire.comAvalo Therapeutics Appoints Biotech Leaders to Board of DirectorsMarch 29, 2024 | marketwatch.comAvalo Therapeutics Shares More than Triple After Co Acquires AlmataBioMarch 29, 2024 | globenewswire.comAvalo Reports 2023 Financial Results and Provides Business UpdatesMarch 29, 2024 | finanznachrichten.deAvalo Therapeutics: Avalo Acquires Anti-IL-1ß mAb and Announces Private Placement Financing of up to $185 MillionMarch 28, 2024 | marketbeat.comTrading was temporarily halted for "AVTX" at 03:03 PM with a stated reason of "LULD pause." Trading set to resume at 04:03 PM. March 28, 2024 | msn.comMicro-Cap Avalo Therapeutics Stock Rallies As It Snaps AlmataBio For Ex-Eli Lilly Drug For Skin DisorderMarch 28, 2024 | marketbeat.comTrading was temporarily halted for "AVTX" at 09:03 AM with a stated reason of "LULD pause."March 28, 2024 | investorplace.comWhy Is Avalo Therapeutics (AVTX) Stock Up 326% Today?March 27, 2024 | globenewswire.comAvalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 MillionFebruary 26, 2024 | finance.yahoo.comAvalo (AVTX) to Report Q4 Earnings: What's in the Cards?January 2, 2024 | benzinga.comAvalo Therapeutics Stock (NASDAQ:AVTX) Dividends: History, Yield and DatesDecember 29, 2023 | marketbeat.comTrading was temporarily halted for "AVTX" at 07:12 PM with a stated reason of "News pending."December 27, 2023 | msn.comAvalo Therapeutics announces a 1-for-240 reverse stock splitDecember 27, 2023 | finance.yahoo.comAvalo Therapeutics Announces 1-for-240 Reverse Stock SplitDecember 18, 2023 | finance.yahoo.comAvalo Therapeutics, Inc. (AVTX) stock forecast and price targetDecember 7, 2023 | finanznachrichten.deAvalo Therapeutics: Avalo Encourages Stockholders to Vote FOR the Reverse Stock SplitDecember 7, 2023 | finance.yahoo.comAvalo Encourages Stockholders to Vote FOR the Reverse Stock SplitNovember 11, 2023 | benzinga.comAvalo Therapeutics Stock (NASDAQ:AVTX) Earnings Dates and Earning CallsNovember 9, 2023 | morningstar.comAvalo Therapeutics Inc AVTXNovember 9, 2023 | finance.yahoo.comAvalo Therapeutics Inc (AVTX) Announces Q3 2023 Financial Results and Strategic AdvancesNovember 9, 2023 | finance.yahoo.comAvalo Reports Third Quarter 2023 Financial Results and Provides Business UpdatesOctober 31, 2023 | finance.yahoo.comAvalo Completes Divestiture of AVTX-800 SeriesSeptember 27, 2023 | finance.yahoo.comBestGrowthStocks.com Issues a Comprehensive Analysis of Avalo TherapeuticsSeptember 26, 2023 | benzinga.comWhy Avalo Therapeutics Stock Is Up TodaySeptember 22, 2023 | benzinga.comWhat's Going On With Avalo Therapeutics (AVTX) Stock?September 18, 2023 | benzinga.comWhy Rubicon Technologies Shares Are Trading Lower By Over 7%; Here Are 20 Stocks Moving PremarketSeptember 13, 2023 | benzinga.comWhy Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionSeptember 13, 2023 | msn.comAvalo drops three rare disease assets amid ongoing challengesSeptember 13, 2023 | benzinga.comWhy Mainz Biomed Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving PremarketSeptember 12, 2023 | marketwatch.comAvalo Therapeutics Shares Rise 53% After Deal to Divest Certain AssetsSeptember 12, 2023 | msn.comWhy Microcap Biotech Firm Avalo Therapeutics Stock Is Trading Higher Today?September 12, 2023 | markets.businessinsider.comCrude Oil Rises 2%; Avalo Therapeutics Shares Spike HigherSeptember 12, 2023 | markets.businessinsider.comAvalo Therapeutics To Sell 800 Series Programs To AUG Therapeutics; Stock SurgesSeptember 12, 2023 | seekingalpha.comAvalo enters agreement to divest AVTX-800 seriesSeptember 12, 2023 | finance.yahoo.comAvalo Enters into Agreement to Divest AVTX-800 SeriesSeptember 6, 2023 | finance.yahoo.comAvalo to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceAugust 22, 2023 | finance.yahoo.comIs Avalo Therapeutics (AVTX) A Hidden Gem or A Value Trap?August 3, 2023 | msn.comAvalo Therapeutics, Inc. (AVTX) Reports Q2 Loss, Misses Revenue EstimatesAugust 3, 2023 | finance.yahoo.comAvalo Reports Second Quarter 2023 Financial Results and Provides Business UpdatesJuly 26, 2023 | benzinga.comAvalo Therapeutics Stock (NASDAQ:AVTX) Insider TradesJuly 6, 2023 | finance.yahoo.comAvalo to Participate in SVB Securities Therapeutics ForumJune 28, 2023 | benzinga.comAvalo Therapeutics 10% Owner Sold $1.03M In Company StockJune 27, 2023 | msn.comAvalo (AVTX) Fails to Meet Goal in Asthma Study, Stock Down 89%June 26, 2023 | msn.comU.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.04% Get Avalo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AVTX and its competitors with MarketBeat's FREE daily newsletter. Email Address POTUS in ‘25 Not Biden/Trump, But (Ad)And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos. Click here now to see my urgent election warning. AVTX Media Mentions By Week AVTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVTX News Sentiment▼-0.980.42▲Average Medical News Sentiment AVTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVTX Articles This Week▼41▲AVTX Articles Average Week Get Avalo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AVTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RedHill Biopharma News Today Pieris Pharmaceuticals News Today Monopar Therapeutics News Today Kiora Pharmaceuticals News Today Purple Biotech News Today FSD Pharma News Today Edesa Biotech News Today Imunon News Today Elevai Labs News Today Akari Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVTX) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist My Default Watchlist Adding Avalo Therapeutics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
